These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16145306)

  • 21. Placebo-controlled trial of transdermal estrogen therapy alone in postmenopausal women: effects on arterial compliance and endothelial function.
    Teede HJ; Liang YL; Kotsopoulos D; Zoungas S; Craven R; McGrath BP
    Climacteric; 2002 Jun; 5(2):160-9. PubMed ID: 12051112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No increase in C-reactive protein levels during intranasal compared to oral hormone therapy in healthy post-menopausal women.
    Hemelaar M; Kenemans P; Schalkwijk CG; Braat DD; van der Mooren MJ
    Hum Reprod; 2006 Jun; 21(6):1635-42. PubMed ID: 16501036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of continuous combined oral estradiol and norethisterone on pulsatility index in internal carotid and uterine arteries in early postmenopausal Taiwanese women---a preliminary study.
    Huang CY; Fu CY; Tseng JY; Yang TS; Chao KC
    Taiwan J Obstet Gynecol; 2009 Mar; 48(1):60-4. PubMed ID: 19346194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women.
    Sumino H; Ichikawa S; Kasama S; Takahashi T; Kumakura H; Takayama Y; Kanda T; Kurabayashi M
    Atherosclerosis; 2006 Dec; 189(2):436-42. PubMed ID: 16469323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial.
    Arrenbrecht S; Boermans AJ
    Osteoporos Int; 2002; 13(2):176-83. PubMed ID: 11908492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of oral and transdermal estrogen therapies on circulating cytokines and chemokines in postmenopausal women with hysterectomy.
    Yasui T; Saijo A; Uemura H; Matsuzaki T; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
    Eur J Endocrinol; 2009 Aug; 161(2):267-73. PubMed ID: 19451213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.
    Oger E; Alhenc-Gelas M; Plu-Bureau G; Mennen L; Cambillau M; Guize L; Pujol Y; Scarabin P
    Thromb Res; 2001 Jan; 101(2):35-43. PubMed ID: 11342204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tibolone, oral or transdermal hormone replacement and colour Doppler analysis: a prospective, randomised pilot study.
    Battaglia C; Mancini F; Persico N; Penacchioni P; Regnani G; Volpe A; de Aloysio D
    Maturitas; 2004 Aug; 48(4):446-55. PubMed ID: 15283938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women.
    Blum A; Hathaway L; Mincemoyer R; Schenke WH; Kirby M; Csako G; Waclawiw MA; Panza JA; Cannon RO
    J Am Coll Cardiol; 2000 Feb; 35(2):271-6. PubMed ID: 10676669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women.
    Cicinelli E; Ranieri G; Maffei S; Colafiglio G; Ria R; Bellavia M; Schonauer MM
    Fertil Steril; 2006 Oct; 86(4):899-904. PubMed ID: 16963035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia.
    Blum A; Lang N; Peleg A; Vigder F; Israeli P; Gumanovsky M; Lupovitz S; Elgazi A; Ben-Ami M
    Am Heart J; 2003 Feb; 145(2):e7. PubMed ID: 12595862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study.
    Duvernoy CS; Rose PA; Kim HM; Kehrer C; Brook RD
    J Womens Health (Larchmt); 2007 Sep; 16(7):963-70. PubMed ID: 17903073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The short-term effects of different regimens of hormone replacement therapy on left ventricular structure and performance in healthy postmenopausal women. A prospective, controlled echocardiographic study.
    Fenkci V; Yilmazer M; Alpaslan M; Onrat E; Fenkci S
    Gynecol Obstet Invest; 2003; 55(3):139-44. PubMed ID: 12865592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women.
    van Baal WM; Kenemans P; Emeis JJ; Schalkwijk CG; Mijatovic V; van der Mooren MJ; Vischer UM; Stehouwer CD
    Fertil Steril; 1999 Apr; 71(4):663-70. PubMed ID: 10202876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of oral and transdermal low-dose estrogen therapy on echocardiographic parameters of cardiac function.
    Vogelvang TE; van der Mooren MJ; Kamp O; Mijatovic V; Visser CA; Kenemans P
    Fertil Steril; 2003 Sep; 80(3):546-53. PubMed ID: 12969696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy.
    Lantto H; Haapalahti P; Tuomikoski P; Viitasalo M; Väänänen H; Sovijärvi AR; Ylikorkala O; Mikkola TS
    Menopause; 2012 Jan; 19(1):82-8. PubMed ID: 21934534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women.
    Rachoń D; Suchecka-Rachoń K; Hak Ł; Myśliwska J
    Menopause; 2006; 13(5):840-5. PubMed ID: 16894332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ
    Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine.
    Os I; Os A; Sandset PM; Bølling S; Seljeflot I; Djurovic S; Westheim A
    Cardiology; 2002; 98(1-2):6-12. PubMed ID: 12373040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.